Company

Instem plc

Headquarters: Stone, United Kingdom

Employees: 480

CEO: Mr. Phil J. Reason

LSE: INS

Market Cap

£143.1 Million

GBP as of July 1, 2023

US$181.8 Million

Market Cap History

Instem plc market capitalization over time

Evolution of Instem plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Instem plc

Detailed Description

Instem plc, together with its subsidiaries, provides information technology applications to the life sciences healthcare market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include ALPHADAS, an eSource EDC system for early phase clinical trials; BioRails for discovery data management; Comet Assay IV, a live video imaging system for reproducible comet slide scoring; and Cyto Study Manager, a data acquisition and reporting solution. The company also offers computational toxicology products and services; Logbook, a repository for information; Morphit for discovery data visualization; NOTOCORD-hem software platforms to acquire, display, and analyze physiological signals; and Provantis, a Windows-based system for organizations and universities in non-clinical evaluation studies. In addition, the company provides Samarind RMS to manage medical product information; submit platform that offers tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; SENDView, an application that simplifies the review of SEND datasets; SEND Explorer, a web-based application with optional data warehousing capabilities; SENDTrial, a Web based solution that can be accessed through a subscription; and standard for exchange of nonclinical data solutions. Further, it provides Sorcerer Colony Counter for automatic plate counter; anonymization, cloud, validation, and safety assessment and regulatory information management software services; and software solutions to extract intelligence from research and development related healthcare data. Additionally, the company develops, manufactures, and supplies software and hardware products for in vitro study data collection and management. Instem plc was founded in 1969 and is headquartered in Stone, the United Kingdom.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Instem plc has the following listings and related stock indices.


Stock: LSE: INS wb_incandescent

Stock: XSTU: 54I wb_incandescent

Details

Headquarters:

Diamond Way

Stone Business Park

Stone, ST15 0SD

United Kingdom

Phone: 44 17 8582 5600

Fax: 44 17 8582 5633